We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$510M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,348
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$22.8M |
| 2 |
Cardinal Health
CAH
|
+$16.4M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.9M |
| 5 |
AbbVie
ABBV
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.1M |
| 2 |
Microsoft
MSFT
|
+$56.8M |
| 3 |
Amazon
AMZN
|
+$50.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Alaunos Therapeutics
TCRT
$4.69M
| $81K | ﹤0.01% |
93
-2
| -2% | -$1.38K |
|
1552
Amneal Pharmaceuticals
AMRX
$5.74B
| $80K | ﹤0.01% |
11,154
-1,484
| -12% | -$15.2K |
|
|
AUD
1553
DELISTED
Audacy, Inc.
AUD
| $79K | ﹤0.01% |
13,561
-363
| -3% | -$2.23K |
|
|
DNR
1554
DELISTED
Denbury Resources, Inc.
DNR
| $77K | ﹤0.01% |
61,959
-1,285
| -2% | -$2.33K |
|
1555
GameStop
GME
$9.58B
| $76K | ﹤0.01% |
55,268
-1,436
| -3% | -$2.81K |
|
1556
KALA BIO
KALA
$11.3M
| $74K | ﹤0.01% |
5
| – | – |
|
1557
Ocular Therapeutix
OCUL
$1.89B
| $72K | ﹤0.01% |
16,280
-1,609
| -9% | -$5.96K |
|
1558
Spyre Therapeutics
SYRE
$8.68B
| $72K | ﹤0.01% |
418
-38
| -8% | -$6.57K |
|
1559
Antero Resources
AR
$10.9B
| $68K | ﹤0.01% |
12,386
-942
| -7% | -$6.79K |
|
1560
Solid Biosciences
SLDB
$786M
| $67K | ﹤0.01% |
775
-116
| -13% | -$12.7K |
|
1561
GoPro
GPRO
$119M
| $66K | ﹤0.01% |
12,173
-321
| -3% | -$2.04K |
|
1562
Harmonic Inc
HLIT
$1.26B
| $64K | ﹤0.01% |
11,556
-244
| -2% | -$1.35K |
|
|
ADMS
1563
DELISTED
Adamas Pharmaceuticals
ADMS
| $64K | ﹤0.01% |
10,392
-1,312
| -11% | -$7.55K |
|
|
NE
1564
DELISTED
Noble Corporation
NE
| $64K | ﹤0.01% |
34,236
-978
| -3% | -$2.3K |
|
|
HMHC
1565
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $63K | ﹤0.01% |
10,963
-288
| -3% | -$1.91K |
|
|
VTLE
1566
DELISTED
Vital Energy
VTLE
| $61K | ﹤0.01% |
1,045
-20
| -2% | -$1.21K |
|
1567
Talphera
TLPH
$71.1M
| $58K | ﹤0.01% |
1,152
-148
| -11% | -$8.89K |
|
|
CHS
1568
DELISTED
Chicos FAS, Inc.
CHS
| $56K | ﹤0.01% |
16,566
-577
| -3% | -$2.1K |
|
|
AVP
1569
DELISTED
Avon Products, Inc.
AVP
| $52K | ﹤0.01% |
13,375
-205
| -2% | -$683 |
|
1570
EyePoint Inc
EYPT
$1.05B
| $51K | ﹤0.01% |
3,096
-130
| -4% | -$2.19K |
|
1571
Plug Power
PLUG
$3.06B
| $51K | ﹤0.01% |
22,651
-596
| -3% | -$1.48K |
|
|
PRTK
1572
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $51K | ﹤0.01% |
12,870
-1,547
| -11% | -$7.36K |
|
|
JCP
1573
DELISTED
J.C. Penney Company, Inc.
JCP
| $51K | ﹤0.01% |
44,341
-1,477
| -3% | -$1.75K |
|
|
ATRS
1574
DELISTED
Antares Pharma, Inc.
ATRS
| $50K | ﹤0.01% |
15,295
-402
| -3% | -$1.16K |
|
|
SBBP
1575
DELISTED
Strongbridge Biopharma plc.
SBBP
| $49K | ﹤0.01% |
15,808
-2,590
| -14% | -$9.51K |
|
Similar funds
ProShare Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ProShare Advisors held 1,686 positions worth $16.7B, up 0.06% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $510M in Q2 2019, closing 61 positions and reducing 1,348 holdings. Its most notable exit was Bemis, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in Dow Inc worth $13.3M.
- ProShare Advisors's largest Q2 2019 buy was Dow Inc: 269,509 shares worth $13.3M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2019, an estimated $22.8M increase.
- ProShare Advisors's biggest Q2 2019 reduction was Apple, cutting an estimated $70.1M.
- ProShare Advisors fully exited Bemis in Q2 2019, selling an estimated $12.7M.
- ProShare Advisors's ten largest holdings make up 21% of its $16.7B portfolio in Q2 2019.
- ProShare Advisors opened 28 new positions and closed 61 in Q2 2019.
- ProShare Advisors's portfolio value rose 0.06% quarter-over-quarter to $16.7B.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.